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Introduction
Primary mucinous carcinoma of the
skin (PMCS) is a rare, slow growing tumor
with a high recurrence rate and occasional
metastasis. It most commonly presents as an
asymptomatic nodule on the face,
particularly the eyelids.1 PMCS is resistant
to radiation and chemotherapy. Historically,
a wide local excision has been the treatment
of choice, but it has high recurrence rates.
While no current definitive treatment
guidelines are available, limited data
suggests that Mohs micrographic surgery
(MMS) may result in significantly lower
recurrence rates than excision.2 We report a
case of recurrent PMCS treated with MMS.
Case Report
A 48-year-old African American
male presented with a two-year history of a
subcutaneous, asymptomatic growth below
his right eye. On clinical exam, a 3x2x1 cm
non-tender, mobile, subcutaneous nodule
was noted on the right lower eyelid and the
zygomatic arch. He underwent excisional
biopsy by plastic surgery two months later.
Pathology showed an island of CK7 positive
and CK 20 negative basaloid cells in the
mucinous stroma consistent with primary
mucinous carcinoma (figures 1, 2 & 3). The
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tumor was approaching the surgical margins.
The patient was lost to follow up and
presented fifteen months later with a
recurrent growth in the right infraorbital
area.
CT imaging showed a soft tissue
mass without bony involvement. An MRI of
the orbits, face and neck showed a 3.8x7x1.1
cm right lower eyelid lesion with no bony
involvement, as well as prominent bilateral
neck lymph nodes and a thyroid mass. Chest
X-ray and metastatic workup were
unremarkable. A fine needle aspiration of
the thyroid mass and cervical lymph node
biopsy were both negative for metastasis.
After a tumor board discussion MMS was
recommended for complete resection of the
tumor with adjuvant radiation therapy.
MMS was performed in 2 stages in an
attempt to clear the deep margins (first stage
shown in figure 4). The second stage showed
clear margins without any residual tumor (the
final MMS defect shown in figure 5). The orbital
septum was violated medially. The patient
underwent reconstruction by plastic surgery two

Figure 1. H&E stain at 10x showing islands of
basaloid cells surrounded by mucinous stroma;
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Figure 2. Deep dermal component at 2x magnification; Figure 3. CK7 positive tumor cells at
20x
days later with right cheek fasciculocutaneous
flaps, right inferior orbicularis oculi muscle flap,
medial canthopexy and lateral canthoplasty. In
addition, the patient received 24 radiation
treatments as per radiation oncology
recommendations to prevent recurrence. Eight
month follow up showed no recurrence.

Discussion
PMCS is a rare adnexal neoplasm of
the mucinous sweat gland, which is often
mistaken for metastasis from extracutaneous
sites, such as gastrointestinal tract or breast.
Clinical presentation may vary, with the
classic presentation of nontender, wellcircumscribed nodules of varying color.1
The most common location of the neoplasm
is the eyelid and eyebrow (49.7%), followed
by non-periorbital face & neck (19.5%) and
scalp (17%).1 Thorough physical
examination must be performed with a focus
on lymph node and breast exam to exclude
metastasis and extracutanous origins,
respectively.
The origin of PMCS is controversial.
It was historically thought to be a variant of
eccrine differentiation, but is now
considered a tumor of apocrine
differentiation.2 Histology shows dermal
avascular, irregular clusters of basaloid cells
with rare mitosis surrounded by abundant
mucin.3 There are three types of PMCS:
pure, mixed, and mucocele.6 Pure types
originate as in-situ and lack an invasive
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ductal component. As mucin builds up and
distends the duct, it displaces the
myoepithelial layer resulting in a classic
histopathology of epithelioid nests in a pool
of mucin without an identifiable in-situ
component. Mixed type is similar to the
pure, but with an invasive ductal component.
Mucocele type displays configurations
which are diastase and hyaluronidase
resistant and can mimic a benign breast
mucocele as well as a ductal breast
adenocarcinoma.4
Workup for suspected PMCS
includes colonoscopy, barium enema and
mammography, to evaluate for
extracutaneous origin. CT imaging may be
necessary to exclude metastases.2 Unlike
PMCS, cutaneous metastases from
mammary adenocarcinoma exhibit a
predilection for the chest and axilla rather
than the face.2 Treatment has conventionally
been wide local excision, but there is a high
rate of recurrence, ranging from 34-36%.5
Metastases of the primary lesion are less
common, occurring in about 14% of cases.6
PMCS is resistant to chemotherapy and
radiation.
In a review of the literature, there are
a few case reports demonstrating the success
of MMS. A small case series of 6 patients
with mucinous carcinoma treated with MMS
showed no recurrence. The 20 to 36 month
follow up indicated that long-term
recurrence rates were lower (13%) then
Johnson et al.
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Figure 4. First stage of MMS ; Figure 5. Second stage, final defect of MMS
recurrences after a wide local excision
(34%).7
In a meta-analysis of PMCS cases
reported between 1952 and 2010, a total of
59 cases were found. Caucasian race,
advanced age, and male gender were
demonstrated as the most likely risk factors.
One hundred and thirty six of the patients in
the meta-analysis were treated with wide
local excision with 1 cm margins and 15
were treated with Mohs surgery. Of those
treated with Mohs, 2 (13%) had recurrence
with no reported metastases. In comparison,
those with wide local excision, 46 (34%)
had recurrence or metastases. Overall
recurrence was 19.6%.2
Although there are no current official guidelines
for treatment of PMCS, the data indicates that
MMS may be a superior treatment with lower
recurrence rates compared to wide local
excision. While additional studies are needed,
our experience thus far supports favorable
outcomes with the use of MMS in treatment of
PMCS.
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